Agnès Portron

685 total citations · 1 hit paper
13 papers, 529 citations indexed

About

Agnès Portron is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Hematology. According to data from OpenAlex, Agnès Portron has authored 13 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Oncology and 3 papers in Hematology. Recurrent topics in Agnès Portron's work include Diabetes Treatment and Management (4 papers), Hemophilia Treatment and Research (3 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). Agnès Portron is often cited by papers focused on Diabetes Treatment and Management (4 papers), Hemophilia Treatment and Research (3 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). Agnès Portron collaborates with scholars based in Switzerland, United States and United Kingdom. Agnès Portron's co-authors include Christophe Schmitt, Richard D. DiMarchi, Neena Sarkar, Katsuyuki Fukutake, Gallia G. Levy, Michaela Lehle, Víctor Jiménez‐Yuste, Sammy Chebon, Midori Shima and Anna Kiialainen and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and Clinical Pharmacokinetics.

In The Last Decade

Agnès Portron

13 papers receiving 513 citations

Hit Papers

Efficacy, safety, and pharmacokinetics of emicizumab prop... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
    2019 273 citations Steven W. Pipe, Midori Shima et al. The Lancet Haematology profile →

Peers

Agnès Portron
Markus Niggli Switzerland
Stan Kurowski United States
N. I. Gallagher United States
Claudia E. Ramirez United States
Sha Guan United States
Gürkan Sengoelge Austria
Natalia Dovlatova United Kingdom
Mario Widel United States
Ulises Novoa Chile
Sherina L. Murden United Kingdom
Markus Niggli Switzerland
Agnès Portron
Citations per year, relative to Agnès Portron Agnès Portron (= 1×) peers Markus Niggli

Countries citing papers authored by Agnès Portron

Since Specialization
Citations

This map shows the geographic impact of Agnès Portron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Portron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Portron more than expected).

Fields of papers citing papers by Agnès Portron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Portron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Portron. The network helps show where Agnès Portron may publish in the future.

Co-authorship network of co-authors of Agnès Portron

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Portron. A scholar is included among the top collaborators of Agnès Portron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Portron. Agnès Portron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yoneyama, Koichiro, Christophe Schmitt, Agnès Portron, et al.. (2023). Clinical pharmacology of emicizumab for the treatment of hemophilia A. Expert Review of Clinical Pharmacology. 16(9). 775–790. 6 indexed citations
2.
Yamamoto, Yumi, et al.. (2023). Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasma. CPT Pharmacometrics & Systems Pharmacology. 12(9). 1213–1226. 4 indexed citations
3.
Pipe, Steven W., Midori Shima, Michaela Lehle, et al.. (2019). Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study. The Lancet Haematology. 6(6). e295–e305. 273 indexed citations breakdown →
4.
5.
6.
Jiménez‐Yuste, Víctor, Midori Shima, Katsuyuki Fukutake, et al.. (2017). Emicizumab Subcutaneous Dosing Every 4 Weeks for the Management of Hemophilia A: Preliminary Data from the Pharmacokinetic Run-in Cohort of a Multicenter, Open-Label, Phase 3 Study (HAVEN 4). Blood. 130(Suppl_1). 86–86. 16 indexed citations
7.
Schwab, Dietmar, Agnès Portron, Sabine Fuerst‐Recktenwald, et al.. (2017). Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study. BMJ Open Ophthalmology. 1(1). e000063–e000063. 8 indexed citations
8.
9.
10.
11.
Bittner, Beate, Keqi Tang, Wantanee Phuapradit, et al.. (2012). 賦形剤N-[8-(2-ヒドロキシベンゾイル)アミノ]カプリル酸ナトリウム含有イバンドロナートについて新規経口製剤選択のための第I相臨床試験. Pharmazie. 67(3). 233–241. 10 indexed citations
12.
Bittner, Beate, Christine McIntyre, Wantanee Phuapradit, et al.. (2012). Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC).. PubMed. 67(3). 233–41. 15 indexed citations
13.
Dupuis, Antoine, William Couet, J. Paquereau, et al.. (2001). Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effect of Imipenem in Healthy Rats. Antimicrobial Agents and Chemotherapy. 45(6). 1682–1687. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Niggli Breakdown of academic impact, for papers by Stan Kurowski Breakdown of academic impact, for papers by N. I. Gallagher Breakdown of academic impact, for papers by Claudia E. Ramirez Breakdown of academic impact, for papers by Sha Guan Breakdown of academic impact, for papers by Gürkan Sengoelge Breakdown of academic impact, for papers by Natalia Dovlatova Breakdown of academic impact, for papers by Mario Widel Breakdown of academic impact, for papers by Ulises Novoa Breakdown of academic impact, for papers by Sherina L. Murden
Rankless by CCL
2026